Guidant Considers Alternatives As Court Enjoins Paclitaxel DELIVER Data
This article was originally published in The Gray Sheet
Executive Summary
Guidant is exploring a supply arrangement that would be consistent with Cook, Inc.'s original licensing agreement with Angiotech Pharmaceuticals in moving forward with a paclitaxel-eluting stent platform